Health Feeds

To Escape Persistent Moves from Valeant Allergan Set to Sell Itself to Actavis

Pharmaceutical Sector - Mon, 11/17/2014 - 12:26

image/jpeg iconAllergan.jpg

To escape an unwanted takeover from Valeant Pharmaceuticals International, the Botox maker Allergan, in its recent defensive move, is planning to sell itself to another bidder Actavis.

read more

Categories: Health Feeds

style="display:inline-block;width:468px;height:60px"
data-ad-client="ca-pub-0856505169071067"
data-ad-slot="9597969280">

Syndicate content